CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of therapies for neurology and oncology diseases in the United States. It develops TPI 287, an investigational chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma...
15 insider purchases on record · latest filing 2026-08-18.
Insiders have also filed 17 sale transactions at CNSP.